BIO vs COHR · rev $651.0M vs P/E 179, rev $7.12B
BIO (BIO) versus Coherent Inc (COHR) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Coherent Inc (COHR) is a scientific & technical instruments company listed on US.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported COHR revenue for 2026-06-30 was $7.12B. Net income was $805.0M. Revenue was up 22.5% from 2025-06-30 to 2026-06-30. COHR currently screens at market cap $73.75B and trailing P/E 178.7.
BIO currently screens at market cap $0. COHR currently screens at market cap $73.75B and trailing P/E 178.7.
Not investment advice. Open the BIO and COHR stock pages for the full models.
Not investment advice.